Lakshmi Chintala, MD

Professional Background

Lakshmi Chintala, MD
Assistant Professor, Hematology/Oncology
Division of Medical Oncology
University of Kansas Medical Center
Kansas City, KS


Lakshmi Chintala, MD, is an assistant professor of medicine at the University of Kansas School of Medicine in Kansas City, KS. Dr Chintala received her medical degree from Andhra Medical College in India. She completed an internal medical residency at the University of Texas Medical Branch. Dr Chintala completed her fellowship in phase I clinical trials at the University of Texas MD Anderson and completed her fellowship in hematology/oncology at the University of Kansas Medical Center. She is board certified in internal medicine for both medical oncology and hematology.

Dr Chintala is a medical oncologist and hematologist with a specific interest in the treatment of head and neck cancer and lung cancer. She has several submitted articles in peer-reviewed journals, including Molecular Cancer Therapeutics, American Journal of Hematology and Molecular Oncology.

Dr Chintala practices at the University of Kansas Cancer Center in Lee’s Summit and is on staff at several community hospitals.

• MBBS, MBBS, Andhra Med. Col., Andhra U.
• Residency, Internal Medicine, University of Texas Medical Branch, Austin, TX
• Clinical Fellowship, Phase 1 clinical trial, University of Texas MD Anderson, Houston, TX
• Clinical Fellowship, Hematology/Oncology, University of Kansas Medical Center, Kansas City, KS

• Hematology , American Board of Internal Medicine-Hematology
• Kansas
• Medical Oncology , American Board of Internal Medicine-Medical Oncology
• Missouri

---

• Hong, David, Ye, Lei, Gagel, Robert, Chintala, Lakshmi, El Naggar, Adel., K., Wright, John, Kurzrock, Razelle. 2008. Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib. Molecular Cancer Therapeutics, 7 (5), 1001-1006. https://doi.org/10.1158/1535-7163.mct-07-2422
• Vemulapalli, Sushma, Chintala, Lakshmi, Tsimberidou, Apostolia‐Maria, Dhillon, Navjot, Lei, Xiudong, Hong, David, Kurzrock, Razelle. 2009. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: The M. D. Anderson Cancer Center experience. American Journal of Hematology, 84 (7), 408-413. https://doi.org/10.1002/ajh.21423
• Chintala, L, Kurzrock, R. 2010. Epidermal growth factor receptor mutation and diverse tumors: case report and concise literature review.. Molecular oncology, 4 (4), 306-8
• Hong, David, Chintala, Lakshmi. 2018. Combining Targeted Therapies, 361-381. https://doi.org/10.1007/978-1-60327-424-1_18